Xvivo Perfusion AB
XVIVO.ST
#5118
Rank
HK$9.84 B
Marketcap
HK$312.60
Share price
-0.89%
Change (1 day)
64.28%
Change (1 year)
Categories

Earnings for Xvivo Perfusion AB (XVIVO.ST)

Earnings in 2024 (TTM): HK$91.98 Million

According to Xvivo Perfusion AB's latest financial reports the company's current earnings are HK$65.99 Million. In 2023 the company made an earning of HK$73.2 Million, an increase over its 2022 earnings that were of HK$17.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Xvivo Perfusion AB from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$91.98 M25.66%
2023 HK$73.2 M309.49%
2022 HK$17.87 M226.49%
2021 HK$5.47 M-110.72%
2020 -HK$51.08 Million-1221.07%
2019 HK$4.55 M-70.61%
2018 HK$15.5 M117.32%
2017 HK$7.13 M146.09%
2016 HK$2.89 M-61.52%
2015 HK$7.53 M-3.88%
2014 HK$7.83 M-39.59%
2013 HK$12.97 M